RIT Capital Partners Plc (LON:RCP)
London · Delayed Price · Currency is GBP · Price in GBX 1,978.00
+30.00 (1.54%)
Aug 13, 2025, 4:35 PM BST
Oncternal Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 221.2 | 189.4 | 204.3 | 218 | 325.9 | 296.8 | Upgrade |
Cash & Short-Term Investments | 221.2 | 189.4 | 204.3 | 218 | 325.9 | 296.8 | Upgrade |
Cash Growth | 53.29% | -7.29% | -6.28% | -33.11% | 9.80% | 385.76% | Upgrade |
Accounts Receivable | - | 3.1 | 28 | 152.3 | 123.6 | 39.8 | Upgrade |
Other Receivables | 126.5 | 1.5 | 1.3 | 5.1 | 4.4 | 1.2 | Upgrade |
Receivables | 126.5 | 4.6 | 29.3 | 157.4 | 128 | 41 | Upgrade |
Prepaid Expenses | - | 1.2 | 4.2 | 7 | 2.9 | 5.1 | Upgrade |
Other Current Assets | 107.5 | 155.8 | 103.2 | 142.7 | 168.3 | 116.5 | Upgrade |
Total Current Assets | 455.2 | 351 | 341 | 525.1 | 625.1 | 459.4 | Upgrade |
Property, Plant & Equipment | 21.6 | 21.7 | 21.6 | 20.7 | 23.1 | 23.6 | Upgrade |
Long-Term Investments | 3,672 | 3,792 | 3,499 | 3,586 | 4,292 | 3,520 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | - | - | 2.5 | Upgrade |
Other Long-Term Assets | 40.4 | 86.6 | 40.1 | 39.4 | 45 | 38.8 | Upgrade |
Total Assets | 4,189 | 4,251 | 3,902 | 4,172 | 4,985 | 4,045 | Upgrade |
Accounts Payable | - | 43.2 | 2.7 | 24.1 | 99.9 | 3.1 | Upgrade |
Accrued Expenses | 13.6 | 32.6 | 15.3 | 14.6 | 28.3 | 29.6 | Upgrade |
Current Portion of Long-Term Debt | 181.2 | 160.2 | 142.9 | 236.2 | 240 | 189 | Upgrade |
Other Current Liabilities | 64.3 | 87.8 | 24.1 | 35.3 | 48.8 | 40.6 | Upgrade |
Total Current Liabilities | 259.1 | 323.8 | 185 | 310.2 | 417 | 262.3 | Upgrade |
Long-Term Debt | 172.1 | 173.7 | 137.9 | 134.4 | 168.9 | 181.5 | Upgrade |
Long-Term Leases | 2 | 2.1 | 2.9 | 3.2 | 3.6 | 3.8 | Upgrade |
Long-Term Deferred Tax Liabilities | - | 0.1 | - | 0.2 | 1.3 | - | Upgrade |
Other Long-Term Liabilities | 5.4 | 20.5 | 3 | 1.8 | 3.9 | 6.5 | Upgrade |
Total Liabilities | 438.6 | 520.2 | 328.8 | 449.8 | 594.7 | 454.1 | Upgrade |
Common Stock | 141.1 | 156.8 | 156.8 | 156.8 | 156.8 | 156.8 | Upgrade |
Additional Paid-In Capital | 45.7 | 45.7 | 45.7 | 45.7 | 45.7 | 45.7 | Upgrade |
Retained Earnings | 3,523 | 3,507 | 3,361 | 3,520 | 4,163 | 3,355 | Upgrade |
Treasury Stock | -21.8 | -25.3 | -36.7 | -46.3 | -23 | -15.3 | Upgrade |
Comprehensive Income & Other | 62.5 | 46.9 | 46.6 | 45.7 | 47.8 | 48 | Upgrade |
Shareholders' Equity | 3,750 | 3,731 | 3,573 | 3,722 | 4,390 | 3,590 | Upgrade |
Total Liabilities & Equity | 4,189 | 4,251 | 3,902 | 4,172 | 4,985 | 4,045 | Upgrade |
Total Debt | 355.3 | 336 | 283.7 | 373.8 | 412.5 | 374.3 | Upgrade |
Net Cash (Debt) | -134.1 | -146.6 | -79.4 | -155.8 | -86.6 | -77.5 | Upgrade |
Net Cash Per Share | -0.94 | -1.01 | -0.53 | -1.00 | -0.55 | -0.49 | Upgrade |
Filing Date Shares Outstanding | 139.4 | 142.05 | 145.93 | 154.17 | 155.77 | 155.83 | Upgrade |
Total Common Shares Outstanding | 139.4 | 142.05 | 145.93 | 154.17 | 155.77 | 155.83 | Upgrade |
Working Capital | 196.1 | 27.2 | 156 | 214.9 | 208.1 | 197.1 | Upgrade |
Book Value Per Share | 26.90 | 26.27 | 24.49 | 24.14 | 28.18 | 23.04 | Upgrade |
Tangible Book Value | 3,750 | 3,731 | 3,573 | 3,722 | 4,390 | 3,590 | Upgrade |
Tangible Book Value Per Share | 26.90 | 26.27 | 24.49 | 24.14 | 28.18 | 23.04 | Upgrade |
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.